É. Thervet

505 total citations
18 papers, 406 citations indexed

About

É. Thervet is a scholar working on Transplantation, Oncology and Surgery. According to data from OpenAlex, É. Thervet has authored 18 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Transplantation, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in É. Thervet's work include Renal Transplantation Outcomes and Treatments (7 papers), Renal and Vascular Pathologies (3 papers) and Neurological Complications and Syndromes (2 papers). É. Thervet is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Renal and Vascular Pathologies (3 papers) and Neurological Complications and Syndromes (2 papers). É. Thervet collaborates with scholars based in France, United States and Germany. É. Thervet's co-authors include P. F. Westeel, Isabelle Étienne, Yvon Lebranchu, Bruno Hurault de Ligny, Yannick Le Meur, M. Büchler, T. Frouget, A.-É. Heng, Denis Glotz and S. Girardot-Seguin and has published in prestigious journals such as Kidney International, Transplantation and American Journal of Transplantation.

In The Last Decade

É. Thervet

17 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
É. Thervet France 7 268 175 73 69 68 18 406
J.R. Pinto Portugal 6 267 1.0× 162 0.9× 90 1.2× 42 0.6× 82 1.2× 11 357
M. González Molina Spain 10 255 1.0× 130 0.7× 78 1.1× 64 0.9× 67 1.0× 26 384
A.D. Pinna Italy 10 163 0.6× 243 1.4× 39 0.5× 54 0.8× 71 1.0× 25 604
David H. Van Buren United States 10 251 0.9× 191 1.1× 82 1.1× 79 1.1× 56 0.8× 19 439
M. Cabello Spain 11 223 0.8× 135 0.8× 58 0.8× 83 1.2× 39 0.6× 35 383
Muhammad Saeed United States 9 184 0.7× 116 0.7× 61 0.8× 71 1.0× 87 1.3× 37 385
T. Frouget France 9 290 1.1× 193 1.1× 87 1.2× 51 0.7× 64 0.9× 16 434
Anh-Dung Hoang Belgium 7 228 0.9× 182 1.0× 45 0.6× 83 1.2× 41 0.6× 11 340
Ronald J. Hen Netherlands 6 316 1.2× 188 1.1× 117 1.6× 94 1.4× 55 0.8× 7 446
S. Flechner United States 7 274 1.0× 134 0.8× 70 1.0× 48 0.7× 47 0.7× 16 393

Countries citing papers authored by É. Thervet

Since Specialization
Citations

This map shows the geographic impact of É. Thervet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Thervet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Thervet more than expected).

Fields of papers citing papers by É. Thervet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Thervet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Thervet. The network helps show where É. Thervet may publish in the future.

Co-authorship network of co-authors of É. Thervet

This figure shows the co-authorship network connecting the top 25 collaborators of É. Thervet. A scholar is included among the top collaborators of É. Thervet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Thervet. É. Thervet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Caillard, Sophie, Nicolás Meyer, Morgane Solis, et al.. (2024). Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients. Kidney International. 107(2). 338–347. 8 indexed citations
2.
Anglicheau, Dany, Rébecca Sberro‐Soussan, Mathilde Lemoine, et al.. (2024). Epstein–Barr Virus‐Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study. Clinical Transplantation. 38(8). e15424–e15424.
3.
Kamar, Nassim, Sven Pischke, Jérôme Dumortier, et al.. (2011). Predictive Factors, Natural History and Outcome of Chronic Hepatitis E Virus Infection in Solid-Organ-Transplant Patients: A Retrospective Multicenter Study. Data Archiving and Networked Services (DANS). 11. 144–144. 2 indexed citations
4.
Joannidès, Robinson, Christelle Monteil, Bruno Hurault de Ligny, et al.. (2011). Immunosuppressant Regimen Based on Sirolimus Decreases Aortic Stiffness in Renal Transplant Recipients in Comparison to Cyclosporine. American Journal of Transplantation. 11(11). 2414–2422. 58 indexed citations
5.
Lebranchu, Yvon, Antoine Thierry, Olivier Toupance, et al.. (2009). Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study. American Journal of Transplantation. 9(5). 1115–1123. 213 indexed citations
6.
Canaud, Guillaume, M.O. Timsit, Julien Zuber, et al.. (2008). Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy. Nephrology Dialysis Transplantation. 24(4). 1325–1327. 21 indexed citations
7.
8.
9.
Dürrbach, Antoine, Lionel Rostaing, Nacéra Ouali, et al.. (2004). USE OF SIROLIMUS AS INITIAL THERAPY AFTER RENAL TRANSPLANTATION : PRELIMINARY RESULTS OF A RANDOMIZED PILOT STUDY IN PATIENT RECEIVING MARGINAL KIDNEYS. Transplantation. 78. 228–228. 3 indexed citations
10.
Bricon, Thierry Le, É. Thervet, Marc Froissart, et al.. (2000). Plasma cystatin C: a better marker of glomerular filtration rate than creatinine in kidney transplantation. Clinical Biochemistry. 33(3). 232–232. 1 indexed citations
11.
Charpentier, B & É. Thervet. (1998). Placebo-Controlled Study of a Humanized Anti-TAC Monoclonal Antibody in Dual Therapy for Prevention of Acute Rejection After Renal Transplantation. Transplantation Proceedings. 30(4). 1331–1332. 15 indexed citations
12.
Legendre, Christophe, et al.. (1995). MONITORING OF AZATHIOPRINE-INDUCED IMMUNOSUPPRESSION WITH THIOPURINE METHYLTRANSFERASE ACTIVITY IN KIDNEY TRANSPLANT RECIPIENTS. Transplantation. 60(7). 639–642. 42 indexed citations
13.
Page, B., É. Thervet, Claire Legendre, & Henri Kreis. (1995). Cryptococcosis after renal transplantation.. PubMed. 27(2). 1732–1732. 3 indexed citations
14.
Legendre, Christophe, C. Rouzioux, N Chkoff, et al.. (1994). Strategy of cytomegalovirus infection prevention in renal transplantation.. PubMed. 23. 331–45. 3 indexed citations
15.
Page, B., et al.. (1994). Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.. PubMed. 26(1). 283–283. 6 indexed citations
16.
Hélénon, O., É. Thervet, J.M. Corréas, et al.. (1994). Renal allograft necrosis: value of color Doppler ultrasound and Gd-DOTA-enhanced magnetic resonance imaging.. PubMed. 26(1). 300–300. 3 indexed citations
17.
Chatenoud, Lucienne, É. Thervet, J Primo, & Bach Jf. (1992). [Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody].. PubMed. 315(6). 225–8. 17 indexed citations
18.
Becquemont, Laurent, É. Thervet, C. Legendre, Paul Landais, & Henri Kreis. (1992). [Effect of pregnancy on renal function after transplantation].. PubMed. 21(41). 1983–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.R. Pinto Breakdown of academic impact, for papers by M. González Molina Breakdown of academic impact, for papers by A.D. Pinna Breakdown of academic impact, for papers by David H. Van Buren Breakdown of academic impact, for papers by M. Cabello Breakdown of academic impact, for papers by Muhammad Saeed Breakdown of academic impact, for papers by T. Frouget Breakdown of academic impact, for papers by Anh-Dung Hoang Breakdown of academic impact, for papers by Ronald J. Hen Breakdown of academic impact, for papers by S. Flechner
Rankless by CCL
2026